While the dearth of suitable MM tumor microenvironment models which accurately represent the MM milieu in patients currently remains a limitation for CAR T assessment, future studies will aim to develop ex-vivo or in vivo models which better recapitulate the complex TGF-β-rich immunosuppressive microenvironment of the MM BM. The gene discussed is TGFB1; the disease is Miyoshi myopathy.